Literature DB >> 4961995

Lysostaphin: an enzymatic approach to staphylococcal disease. II. In vivo studies.

W Schaffner, M A Melly, M G Koenig.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1967        PMID： 4961995      PMCID： PMC2591258     

Source DB:  PubMed          Journal:  Yale J Biol Med        ISSN： 0044-0086


× No keyword cloud information.
  9 in total

1.  The effect of antimicrobial drugs on an experimental staphylococcal infection in mice.

Authors:  J C BATTEN; P A P DINEEN; R M MCCUNE
Journal:  Ann N Y Acad Sci       Date:  1956-08-31       Impact factor: 5.691

2.  Antigen-antibody reactions in gels.

Authors:  O OUCHTERLONY
Journal:  Acta Pathol Microbiol Scand       Date:  1949

Review 3.  Therapeutic aspects of staphylococcal disease.

Authors:  W M Kirby
Journal:  Ann N Y Acad Sci       Date:  1965-07-23       Impact factor: 5.691

4.  Staphylococcal L-forms--ecologic perspectives.

Authors:  B M Kagan
Journal:  Ann N Y Acad Sci       Date:  1965-07-23       Impact factor: 5.691

5.  Factors relating to the virulence of staphylococci. I. Comparative studies on two colonial variants.

Authors:  M G KOENIG
Journal:  Yale J Biol Med       Date:  1962-06

6.  Determinants of infection in the peritoneal cavity. I. Response to and fate of Staphylococcus aureus and Staphylococcus albus in the mouse.

Authors:  Z A COHN
Journal:  Yale J Biol Med       Date:  1962-08

7.  Factors relating to the virulence of Staphylococci. III. Antibacterial versus antioxic immunity.

Authors:  M G KOENIG; M A MELLY; D E ROGERS
Journal:  J Exp Med       Date:  1962-11-01       Impact factor: 14.307

8.  Factors relating to the virulence of Staphylococci. II. Observations on four mouse-pathogenic strains.

Authors:  M G KOENIG; M A MELLY; D E ROGERS
Journal:  J Exp Med       Date:  1962-11-01       Impact factor: 14.307

9.  The behavior of virulent and avirulent staphylococci in the tissues of normal mice.

Authors:  J M SMITH; R J DUBOS
Journal:  J Exp Med       Date:  1956-01-01       Impact factor: 14.307
  9 in total
  12 in total

1.  Production of Lysostaphin by Nonproprietary Method Utilizing a Promoter from Toxin-Antitoxin System.

Authors:  Anna Mądry; Agnieszka Jendroszek; Grzegorz Dubin; Benedykt Wladyka
Journal:  Mol Biotechnol       Date:  2019-10       Impact factor: 2.695

2.  Mechanism and suppression of lysostaphin resistance in oxacillin-resistant Staphylococcus aureus.

Authors:  M W Climo; K Ehlert; G L Archer
Journal:  Antimicrob Agents Chemother       Date:  2001-05       Impact factor: 5.191

3.  Comparison of four methods for determining lysostaphin susceptibility of various strains of Staphylococcus aureus.

Authors:  Caroline M Kusuma; John F Kokai-Kun
Journal:  Antimicrob Agents Chemother       Date:  2005-08       Impact factor: 5.191

4.  Lysostaphin treatment of experimental aortic valve endocarditis caused by a Staphylococcus aureus isolate with reduced susceptibility to vancomycin.

Authors:  R L Patron; M W Climo; B P Goldstein; G L Archer
Journal:  Antimicrob Agents Chemother       Date:  1999-07       Impact factor: 5.191

5.  Efficacy and safety of topical lysostaphin treatment of persistent nasal carriage of Staphylococcus aureus.

Authors:  K E Quickel; R Selden; J R Caldwell; N F Nora; W Schaffner
Journal:  Appl Microbiol       Date:  1971-09

6.  Combinations of lysostaphin with beta-lactams are synergistic against oxacillin-resistant Staphylococcus epidermidis.

Authors:  Nandini Kiri; Gordon Archer; Michael W Climo
Journal:  Antimicrob Agents Chemother       Date:  2002-06       Impact factor: 5.191

7.  Lysostaphin treatment of experimental methicillin-resistant Staphylococcus aureus aortic valve endocarditis.

Authors:  M W Climo; R L Patron; B P Goldstein; G L Archer
Journal:  Antimicrob Agents Chemother       Date:  1998-06       Impact factor: 5.191

8.  Bioluminescence and 19F magnetic resonance imaging visualize the efficacy of lysostaphin alone and in combination with oxacillin against Staphylococcus aureus in murine thigh and catheter-associated infection models.

Authors:  Tobias Hertlein; Volker Sturm; Udo Lorenz; K Sumathy; Peter Jakob; Knut Ohlsen
Journal:  Antimicrob Agents Chemother       Date:  2013-12-23       Impact factor: 5.191

9.  Rapid identification of Staphylococcus aureus by using lysostaphin sensitivity.

Authors:  P J Severance; C A Kauffman; J N Sheagren
Journal:  J Clin Microbiol       Date:  1980-06       Impact factor: 5.948

10.  Evaluation of Topical Lysostaphin as a Novel Treatment for Instrumented Rhesus Macaques (Macaca mulatta) Infected with Methicillin-Resistant Staphylococcus aureus.

Authors:  Christopher E Cheleuitte-Nieves; Leslie L Diaz; Maria Pardos de la Gandara; Alejandra Gonzalez; Winrich A Freiwald; Hermínia M de Lencastre; Alexander Tomasz; Chad W Euler
Journal:  Comp Med       Date:  2020-08-13       Impact factor: 0.982
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.